Elisa Capizzi
University of Bologna
29 Papers
299 Citations
Elisa Capizzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 28 publications.
Chat about Author
Papers
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples
Annalisa Altimari,Dario de Biase,Giovanna De Maglio,Elisa Gruppioni,Elisa Capizzi,Alessio Degiovanni,Antonia D'Errico,Annalisa Pession,Stefano Pizzolitto,Michelangelo Fiorentino,Giovanni Tallini +10 more
TL;DR: This comparison showed the superiority of next-generation sequencing over the other techniques in terms of sensitivity and specificity and will replace Sanger sequencing as the reference technique for diagnostic detection of KRAS mutation in archival tumor tissues.
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.
Francesco Vasuri,Rita Golfieri,Michelangelo Fiorentino,Elisa Capizzi,Matteo Renzulli,Antonio Daniele Pinna,Walter F. Grigioni,Antonia D’Errico-Grigioni +7 more
TL;DR: The results support the idea that OATP could be used together with K7/19 to identify a phenotypical “spectrum” in HCC progression, and show a progressive loss in OatP immunoreactivity that correlates with the gain of a biliary phenotype.
49
Blood and Tissue Biomarkers in Prostate Cancer: State of the Art
TL;DR: The authors focus here on the most recently reported tissue and circulating biomarkers for PCa whose application in clinical practice is either current or expected in the near future.
45
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.
Karim Rihawi,Roberta Alfieri,Michelangelo Fiorentino,Francesca Fontana,Elisa Capizzi,Andrea Cavazzoni,Mario Terracciano,Silvia La Monica,Alberto Ferrarini,Genny Buson,Pier Giorgio Petronini,Andrea Ardizzoni +11 more
TL;DR: The tumor molecular profile of a patient who failed to respond to Crizotinib is investigated and the MYC gene may be implicated in the mechanism of primary resistance to ALK inhibitors, and potential MYC-directed inhibition strategies to overcome primary resistance in advanced ALK-rearranged NSCLC are suggested.
43
Studies on immunoproteasome in human liver. Part I: Absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis
Francesco Vasuri,Elisa Capizzi,Elena Bellavista,Michele Mishto,Michele Mishto,Aurelia Santoro,Michelangelo Fiorentino,Miriam Capri,Matteo Cescon,Gian Luca Grazi,Walter F. Grigioni,Antonia D’Errico-Grigioni,Claudio Franceschi +12 more
TL;DR: The most striking result was the concomitant presence in hepatocyte cytoplasm of all healthy subjects, including the pediatric cases, of constitutive proteasome and immunoproteasome subunits, as well as PA28alphabeta.
37